NASDAQ
RCEL
Last Price
US $4.02
KEY FIGURES
MKT CAP
$99.9M
EPS
TTM
$-148.45
PEG
TTM
-
P/E
TTM
N/M
P/S
TTM
0.02x
YIELD
0.00%
GROWTH
Revenue Y/Y
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
Avita Medical Inc. cash flow to debt ratio of -67.74% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial stability - Healthy cash flow growth.
Avita Medical Inc.'s free cash flow has increased -43.48% from $-58.27M last year to $-32.93M, signaling increasing performance
Financial risk - Healthy debt to equity ratio.
Avita Medical Inc.'s debt to equity ratio is -2.08, signaling that the company spent its equity and risk bankruptcy.
Financial risk - Healthy debt to equity ratio development.
Avita Medical Inc.'s debt to equity ratio is -2.08, signaling that the company spent its equity and risk bankruptcy.
Financial risk - Net debt/EBITDA.
Avita Medical Inc. has negative EBITDA, making leverage ratio unreliable
Financial risk - ICR.
Avita Medical Inc.'s interest coverage ratio is -7.61, which means that the company struggles to meet interest obligations, signaling financial risk.
Financial stability - Profit margin growth.
Avita Medical Inc.'s profit margin has increased (-34.89%) in the last year from -96.26% to -62.67%, signaling increasing performance
Financial risk - Short term assets vs short term liabilities.
Avita Medical Inc.'s short-term liabilities of $62.68M exceed its short-term assets of $35.49M, signaling financial risk
Decreasing performance - ROA.
Avita Medical Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Increasing performance - Absolute return on equity.
Avita Medical Inc.'s return on equity of 305.45%, is higher than 15.00%, indicating good performance
Decreasing performance - Earnings quality.
Avita Medical Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Decreasing performance - Earnings stability.
Avita Medical Inc. had positive net income in only 0.00 out of 5 years, indicating unstable earnings
Decreasing performance - Free cash flow.
Avita Medical Inc. has negative free cash flow, indicating the company is burning cash rather than generating it
Decreasing performance - FCF yield.
Avita Medical Inc. has negative free cash flow, indicating cash burn
Increasing performance - Healthy earnings growth.
Avita Medical Inc.'s yearly earnings has increased -21.44% since last year from $-61.84M to $-48.59M, signaling increasing performance
Increasing performance - Healthy revenue growth.
Avita Medical Inc.'s yearly revenue has increased 11.45% since last year from $64.25M to $71.61M, signaling increasing performance
Decreasing performance - ROIC.
ROIC -127.38% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Increasing performance - 3-year revenue CAGR.
Avita Medical Inc.'s 3-year revenue CAGR of 27.66% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Avita Medical Inc. had revenue growth in 5.00 out of 5 years, indicating consistent revenue performance
Decreasing performance - ROE consistency.
Avita Medical Inc. had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity
Overvalued - DCF valuation.
Avita Medical Inc. has insufficient data to evaluate this check.
Overvalued - Earnings yield.
Avita Medical Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
Avita Medical Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
Overvalued - EV/EBITDA.
Avita Medical Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable
Overvalued - PEG ratio value.
Avita Medical Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - P/B ratio.
Avita Medical Inc. has negative shareholder equity; price-to-book is not meaningful and the check fails
Undervalued - P/S ratio.
Avita Medical Inc. has a price-to-sales ratio of 0.02x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
305.45%
Return on equity
ROIC: -127.38%
Valuation History
-0.11X
Price to Earnings
EV/EBITDA: -3.7X
Cash flow
Profit margin
25.11%
(FY vs FY)
EBITDA Y/Y
-11.05%
(FY vs FY)
Cash flow Y/Y
-6.45%
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $4.02
—
Default assumptions
EBITDA Multiple
Fair Value
Market $4.02
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.